TAG:
laboratory company
Lab Industry Attracting New Investment Dollars
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Professional investors with access to hundreds of millions of dollars of investment capital are closely scrutinizing the clinical laboratory industry. They are encouraged by the recent financial performance of public laboratory companies. For independent laboratory owners, th…
Several Labs Planning A Public Stock Offering
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: During the past six years, no general clinical laboratory company has undergone an initial public stock offering (IPO). That will certainly change during the next 24 months. There are several private lab companies which want to go public. But this business strategy can only s…
Lab “Home Brews” Web Solution for Test Results
CEO SUMMARY: Internet-enabled lab test ordering and results reporting may help independent commercial labs and hospital laboratory outreach programs become more competitive against the two blood brothers. In eastern Pennsylvania, Clinical Laboratories, Inc. introduced Web-based lab test r…
BRLI Ready To Leverage Physician Relationship
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: As healthcare E-commerce rapidly approaches, clinical laboratories will find they have a built-in competitive advantage—their existing business relationship and communication links to physician offices. Bio-Reference Laboratories, Inc. is moving rapidly to capitalize on thi…
“May 8, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
There’s another healthcare Ecommerce company starting up. This one’s directed at the clinical laboratory industry. To be called “LabPortal.com,” it’s connected to Golder, Thoma, Cressey, Rauner Inc., Park City Solutions, and American Medical Laboratories. L…
Independent California Lab Decides to Exit Business
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: Market forces in California continue to put independent laboratories under sustained financial stress. One laboratory owner decided it was an auspicious time to sell his lab. That sale, of POISONLAB to Laboratory Corporation of America, was announced earlier this month. There…
Client Bill Pricing Policy Rises To Medicare Level
By Robert Michel | From the Volume VII No. 3 – February 14, 2000 Issue
CEO SUMMARY: Within the laboratory industry, there has been a decade-long debate over whether offering discount prices in client bill states could violate some Medicare regulations. UroCor, Inc. decided that an OIG opinion issued in December to a pathology company signaled a potential cha…
Abbott, CARESIDE, Bio-Reference Labs, DIANON Systems
By Robert Michel | From the Volume VII No. 1 – January 3, 2000 Issue
SWARM OF LAWSUITS NOW PLAGUES ABBOTT LABS PAYING A $100 MILLION FINE TO THE Food and Drug Administration (FDA) did not end Abbott Laboratories, Inc.’s problems related to its diagnostic test kits and reagents. Since payment of the FDA fine last month, Abbott has been serv…
Dynacare Buys LabSouth as Gateway into Alabama
By Robert Michel | From the Volume VII No. 1 – January 3, 2000 Issue
CEO SUMMARY: With the acquisition of ARL/LabSouth, based in Birmingham and Montgomery, Dynacare immediately becomes a major player in the Alabama marketplace. Several interesting aspects to the sale demonstrate that it is becoming increasingly difficult for independent commercial laborato…
Pap Smear Marketplace Shifting into High Gear
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: It took just four years to shake out the weakest competitors in the emerging field of automated cytology. Now only TriPath Imaging, Inc. and Cytyc Corporation remain in competition. Indications are that this will be a nasty battle. Pathologists and lab executives contemplatin…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized